Clinigen deal falls flat
Speciality pharmaceutical and services business Clinigen (CLIN:AIM) declines 1.6% to 499.75p despite an early morning rally, as the market chews over its latest attempt to rejuvenate its plateauing revenues streams.Clinigen, a...
14 April 2014